Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension

QR Code

Brinzolamide ophthalmic suspension: a review of its pharmacology and use in the treatment of open angle glaucoma and ocular hypertension

Michele IesterClinica Oculistica, University of Genoa, ItalyAbstract: Brinzolamide is a white powder commercially formulated as a 1% ophthalmic suspension to reduce intraocular pressure (IOP). Pharmacologically, brinzolamide is a highly specific, non-competitive, reversible, and effective inhibitor...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Michele Iester
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2008
Sujets:	Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/b8a04ede59ae4f7a952418cde75aa61c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Update and optimal use of a brinzolamide-timolol fixed combination in open-angle glaucoma and ocular hypertension
par: Syed MF, et autres
Publié: (2011)

Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension
par: Yoshikawa K, et autres
Publié: (2014)

Efficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertension [Erratum]
par: Yoshikawa K, et autres
Publié: (2014)

Safety and efficacy of a fixed versus unfixed brinzolamide/timolol combination in Japanese patients with open-angle glaucoma or ocular hypertension
par: Nagayama M, et autres
Publié: (2014)

Clinical effectiveness of brinzolamide 1%–brimonidine 0.2% fixed combination for primary open-angle glaucoma and ocular hypertension
par: Sharma S, et autres
Publié: (2015)

Preference for a fixed combination of brinzolamide/timolol versus dorzolamide/ timolol among patients with open-angle glaucoma or ocular hypertension
par: Sanseau A, et autres
Publié: (2013)

Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
par: Henny JM Beckers, et autres
Publié: (2009)

Phase III safety and efficacy study of long-term brinzolamide/timolol fixed combination in Japanese patients with open-angle glaucoma or ocular hypertension
par: Nakajima M, et autres
Publié: (2013)

Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study
par: Altafini R, et autres
Publié: (2015)

Safety and tolerability of tafluprost in treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
par: Dorota Pozarowska
Publié: (2010)

A patient preference comparison of Azarga&trade; (brinzolamide/timolol fixed combination) vs Cosopt&reg; (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertension
par: Thomas K Mundorf, et autres
Publié: (2008)

Efficacy and safety of combination therapy with latanoprost after a change in therapeutic regimen from timolol to brinzolamide in Japanese adult patients with primary open-angle glaucoma and ocular hypertension: open, non-randomized 12-week study
par: Shusaku Ishikawa, et autres
Publié: (2008)

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
par: Miguel A Teus, et autres
Publié: (2009)

Clinical appraisal of tafluprost in the reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension
par: Makoto Aihara
Publié: (2010)

Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension
par: Sophia K Mirza, et autres
Publié: (2010)

Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension
par: Lorenz K, et autres
Publié: (2011)

Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
par: Laube T, et autres
Publié: (2012)

Fixed combination of bimatoprost and timolol in patients with primary open-angle glaucoma or ocular hypertension with inadequate IOP adjustment
par: Gerrett Brief, et autres
Publié: (2010)

Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension
par: Whitson JT, et autres
Publié: (2013)

Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
par: Wang N, et autres
Publié: (2020)

Safety and efficacy of fixed-combination travoprost/timolol in patients with open-angle glaucoma or ocular hypertension not controlled with timolol monotherapy
par: Jordão MLS, et autres
Publié: (2014)

Efficacy and safety of prostaglandin analogues in patients with predominantly primary open-angle glaucoma or ocular hypertension: a meta-analysis
par: Oghenowede Eyawo, et autres
Publié: (2009)

Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review
par: Andrea Russo, et autres
Publié: (2009)

Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients
par: Makoto Ishikawa, et autres
Publié: (2009)

Differential pharmacology and clinical utility of preservative-free tafluprost in the treatment of ocular hypertension and glaucoma
par: Ermiş&nbsp;SS
Publié: (2012)

Brinzolamide-timolol suspension: acceptability and side effect profile
par: Doherty MD, et autres
Publié: (2011)

Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension
par: Bhagat P, et autres
Publié: (2014)

Comparative studies of RNFL thickness measured by OCT with global index of visual fields in patients with ocular hypertension and early open angle glaucoma
par: Sergios Taliantzis, et autres
Publié: (2009)

A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension
par: Douglas J Rhee, et autres
Publié: (2008)

Preliminary results following the use of a fixed combination of timolol&ndash;brimonidine in patients with ocular hypertension and primary open-angle glaucoma
par: Dimitris Papaconstantinou, et autres
Publié: (2009)

Tolerability and effectiveness of preservative-free dorzolamide&ndash;timolol (preservative-free Cosopt&reg;) in patients with open-angle glaucoma or ocular hypertension
par: Cindy Hutnik, et autres
Publié: (2010)

An observational study of bimatoprost 0.01% in treatment-na&iuml;ve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial
par: Nixon DR, et autres
Publié: (2012)

A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension
par: David A Godfrey, et autres
Publié: (2009)

A combined analysis of five observational studies evaluating the efficacy and tolerability of bimatoprost/timolol fixed combination in patients with primary open-angle glaucoma or ocular hypertension
par: Pfennigsdorf S, et autres
Publié: (2013)

Randomized, Double-Masked, Placebo-Controlled Dose Escalation Study of TAK-639 Topical Ophthalmic Solution in Subjects with Ocular Hypertension or Primary Open-Angle Glaucoma
par: Martin P, et autres
Publié: (2020)

Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
par: Bruce I Gaynes, et autres
Publié: (2008)

Role of hypertension as a risk factor for open-angle glaucoma: a systematic review and meta-analysis
par: Ririn Nislawati, et autres
Publié: (2021)

Blood pressure, ocular perfusion pressure and open-angle glaucoma in patients with systemic hypertension
par: Cantor E, et autres
Publié: (2018)

Profile of netarsudil ophthalmic solution and its potential in the treatment of open-angle glaucoma: evidence to date
par: Dasso L, et autres
Publié: (2018)

Correlation between ocular perfusion pressure and ocular pulse amplitude in glaucoma, ocular hypertension, and normal eyes
par: Figueiredo BP, et autres
Publié: (2013)